Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;86(5):e148-e151.
doi: 10.1016/j.jinf.2023.01.015. Epub 2023 Jan 18.

Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study

Sung-Woon Kang  1 , Heedo Park  2 , Ji Yeun Kim  1 , So Yun Lim  1 , Sohyun Lee  2 , Joon-Yong Bae  2 , Jeonghun Kim  2 , Euijin Chang  1 , Seongman Bae  1 , Jiwon Jung  1 , Min Jae Kim  1 , Yong Pil Chong  1 , Sang-Oh Lee  1 , Sang-Ho Choi  1 , Yang Soo Kim  1 , Man-Seong Park  3 , Sung-Han Kim  4
Affiliations

Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study

Sung-Woon Kang et al. J Infect. 2023 May.
No abstract available

Keywords: COVID-19; Infection dynamic; Isolation policy; SARS-CoV-2; Viral shedding.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interests The authors have no conflicts of interest to declare.

Figures

Fig 1
Fig. 1
Kaplan–Meier curves for genomic and subgenomic RNA clearance according to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant. A. Comparison of genomic RNA clearance. B. Comparison of subgenomic RNA clearance. C. Comparison of viable virus shedding period.
See this image and copyright information in PMC

Comment in

References

    1. Kandel C., Lee Y., Taylor M., Lanes A., McCready J., et al. Viral Dynamics of the SARS-CoV-2 Omicron Variant among household contacts with 2 or 3 COVID-19 vaccine doses. J Infect. 2022;85:666–670. - PMC - PubMed
    1. Tegally H., Moir M., Everatt J., Giovanetti M., Scheepers C., Wilkinson E., et al. Emergence of SARS-CoV-2 omicron lineages BA.4 and BA.5 in South Africa. Nat Med. 2022;28(9):1785–1790. 2022/09/01. - PMC - PubMed
    1. Garrett N., Tapley A., Andriesen J., Seocharan I., Fisher L.H., Bunts L., et al. High asymptomatic carriage with the omicron variant in South Africa. Clin Infect Dis. 2022;75(1):e289–e292. - PMC - PubMed
    1. Boulware D.R., Murray T.A., Proper J.L., Tignanelli C.J., Buse J.B., Liebovitz D.M., et al. Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial. Clin Infect Dis. 2022:ciac772. - PMC - PubMed
    1. Ending Isolation and Precautions for People with COVID-19: interim Guidance [Internet]. Centers for Disease Control and Prevention. 2022 [cited December 26, 2022]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html.

Publication types